Their microneedles are specifically designed to deliver macromolecules, including peptides, such as GLP-1 agonist drugs
Answer: Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications that includes semaglutide (Wegovy, Ozempic, Rybelsus), tirzepatide (Zepbound, Mounjaro), liraglutide (Victoza, Saxenda), and orforglipron (Foundayo), have become increasingly popular for obesity treatment (Mehrtash, JAMA Intern Med 2025)
Glinide compounds like repaglinidewhich also act by closing the ATP-dependent potassium channelsappear to be associated with a similar risk of adverse cardiovascular sequelae than sulfonylureas [13]
Even in these scenarios, FDA expects rigorous justification and patient-specific prescriptions
In other words, youll usually pay more for a Tier 4 drug than a Tier 1 drug
Treatment of type 2 diabetes by targeting interleukin-1: a meta-analysis of 2921 patients